P3 Health PartnersPIII +2.43%48 3-Year ROIIC % is 16.50 as of Dec. 2025. GuruFocus rates PIII with a GF Score™ of 48/100 and a GF Value™ of $9.20 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 619 Healthcare Providers & Services companies, P3 Health Partners ranks better than 71.08% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
P3 Health Partners's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 16.50%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for P3 Health Partners's 3-Year ROIIC % or its related term are showing as below:
PIII's 3-Year ROIIC % is ranked better than 71.08% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs PIII: 16.50
P3 Health Partners (NAS:PIII) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
P3 Health Partners 3-Year ROIIC % Related Terms
P3 Health Partners 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PIII vs EHSI, CDIX, DCGO: 3-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's 3-Year ROIIC % falls into.
P3 Health Partners's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -270.301 (Dec. 2025) - -245.961 (Dec. 2022) )
/
( 654.71 (Dec. 2025) - 802.254 (Dec. 2022) )
=
-24.34
/
-147.544
=
16.50%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
P3 Health Partners (PIII) has a 3-Year ROIIC % of 16.50 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #179 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 28.9%.
Is P3 Health Partners' 3-Year ROIIC % too high?
P3 Health Partners' current 3-Year ROIIC % is 16.50. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. P3 Health Partners' value of 16.50 is 403% above this industry median. Based on the distribution chart, P3 Health Partners ranks #179 out of 619 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, P3 Health Partners has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' 3-Year ROIIC % compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #179 out of 619 companies for 3-Year ROIIC %. This puts P3 Health Partners in the upper half of its industry. The industry median 3-Year ROIIC % is 3.28. P3 Health Partners' value of 16.50 is 403% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. P3 Health Partners's current 3-Year ROIIC % of 16.50 is 403% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current 3-Year ROIIC % is 16.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.20, compared to a current price of $10.53 — trading 14.5% above its estimated fair value. The current 3-Year ROIIC % is 16.50 and 403% above the Healthcare Providers & Services industry median of 3.28. P3 Health Partners' overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For P3 Health Partners (PIII), the current 3-Year ROIIC % is 16.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.53 is trading 14.5% above its estimated GF Value™ of $9.20.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
3-Year ROIIC %: 16.50
GF Value™: $9.20 vs. price of $10.53 (14.5% above fair value)
Industry Position: 403% above the Healthcare Providers & Services median (#179 of 619)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
48GF Score
Get the complete analysis for PIII
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 
